Safety and antibody response after one and/or two doses of BNT162b2 Anti‐SARS‐CoV‐2 mRNA vaccine in patients treated by CAR T cells therapy

  Thomas Gastinne ¹ AuthorId : 157099
Author

  Amandine Le Bourgeois ¹ AuthorId : 11987776
Author

  Marianne Coste‐burel ¹ AuthorId : 12449758
Author

  Thierry Guillaume ^{1, 2} AuthorId : 994028
Author ORCID : https://orcid.org/0000-0001-5482-8565

  Pierre Peterlin ¹ AuthorId : 1282932
Author

  Alice Garnier ¹ AuthorId : 567151
Author

  Berthe‐marie Imbert ¹ AuthorId : 12449761
Author

  Thomas Drumel ¹ AuthorId : 12449762
Author

  Beatrice Mahe ¹ AuthorId : 544873
Author

  Viviane Dubruille ¹ AuthorId : 780888
Author

  Nicolas Blin ¹ AuthorId : 11988637
Author

  Anne Lok ¹ AuthorId : 1515175
Author

  Cyrille Touzeau ¹ AuthorId : 1371901
Author ORCID : https://orcid.org/0000-0003-0275-2575

  Benoit Tessoulin ¹ AuthorId : 1004900
Author ORCID : https://orcid.org/0000-0001-7600-3329

  Maxime Jullien ¹ AuthorId : 12357973
Author ORCID : https://orcid.org/0000-0001-6915-6570

  Sophie Vanthygem ¹ AuthorId : 12449763
Author

  Marie C Béné ¹ AuthorId : 1502605
Author ORCID : https://orcid.org/0000-0002-6569-7414

  Philippe Moreau ¹ AuthorId : 239812
Author ORCID : https://orcid.org/0000-0003-1780-8746

  Steven Le Gouill ¹ AuthorId : 404967
Author

  Patrice Chevallier ^{1, 3} AuthorId : 464614
Author ORCID : https://orcid.org/0000-0003-3142-5581